Metiscan, Inc. Considers Becoming Apple iPhone Developer

DALLAS, TX--(Marketwire - May 19, 2009) - Metiscan, Inc. (PINKSHEETS: MTIZ), a leading provider of products and services that streamline the management of diagnostic imaging facilities, today announced that the Company is considering adding Apple iPhone Development to its portfolio of products and services.

An integral part of Management's strategic plan is the intent to grow the Company through making key acquisitions of both companies and developing technologies prevalent in today's emerging markets. To date, the Company has been actively involved in investing, developing, and enhancing its core Electronic Medical (Health) Records business through its subsidiary, Metiscan Managed Services, Inc. Already at the threshold of capitalizing on the new multi-billion dollar stimulus package as established by President Barack Obama, the Company is confident that continuing to invest in medical technologies will yield a high rate of return in the upcoming years.

In keeping with Management's overall goal and vision of investing in emerging technologies, the Company is seeking to take advantage of the fast growing software applications marketplace for the Apple iPhone. "Management has been evaluating becoming an Apple iPhone Developer for quite some time," commented Bryan A. Scott, President and CEO of Metiscan, Inc. "We believe that the addition of the iPhone development to our organization will allow us to further diversify our software offering and enable us to access new revenue streams and profits. Part of the strategy we are considering is rapid growth through acquisition of iPhone applications with our initial focus targeted towards business related iPhone applications."

On April 24, 2009 Apple announced that it sold its 1 Billionth iPhone Application through its revolutionary App Store. It has been estimated that the App Store currently features over 35,000 applications built by thousand of developers. This summer Apple plans on releasing the iPhone OS 3.0 software update which will provide over 1,000 new APIs that will enable countless new features for iPhone developers to take advantage of. Applications are sold under various categories to include Business, Finance, Entertainment, Games, Medical, and Lifestyle. Applications on average range in price from free to $3.99+ per application. It is not unheard of for a single developer with a single application to exceed more than $100,000 in revenues per month.

About Metiscan, Inc.

Metiscan, Inc. is a national provider of products and services that streamline the management and operation functions of diagnostic imaging facilities, radiology groups, in-office imaging groups, small hospitals and physician offices and is an operator of an MRI facility located in Pottsville, PA. Metiscan's keystone product is a web-based radiology information system that interfaces Radiology Information System (RIS), Teleradiology and PACS (Picture Archiving and Communication System) for its clients. Metiscan also provides information management and operations support for diagnostic imaging facilities through complete revenue cycle management, electronic health records or EHR, medical transcription services and functional training as needed.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.